Diabetes Care
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Dixon, J. B.
Right arrow Articles by O’Brien, P. E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Dixon, J. B.
Right arrow Articles by O’Brien, P. E.
Social Bookmarking
 Add to CiteULike   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?
Diabetes Care 25:358-363, 2002
© 2002 by the American Diabetes Association, Inc.


Emerging Treatments and Technologies
Original Article

Health Outcomes of Severely Obese Type 2 Diabetic Subjects 1 Year After Laparoscopic Adjustable Gastric Banding

John B. Dixon, MBBS1 and Paul E. O’Brien, MD1

1 From the Monash University Department of Surgery, Alfred Hospital, Melbourne, Victoria, Australia

OBJECTIVE—To prospectively examine the effect of weight loss 1 year after laparoscopic adjustable gastric band surgery on a broad range of health outcomes in 50 diabetic subjects.

RESEARCH DESIGN AND METHODS—A total of 50 (17 men, 33 women) of 51 patients with type 2 diabetes, from a total of 500 consecutive patients, were studied preoperatively and again 1 year after surgery.

RESULTS—Preoperative weight and BMI (means ± SD) were 137 ± 30 kg and 48.2 ± 8 kg/m2, respectively; at 1 year, weight and BMI were 110 ± 24 kg and 38.7 ± 6 kg/m2, respectively. There was significant improvement in all measures of glucose metabolism. Remission of diabetes occurred in 32 patients (64%), and major improvement of glucose control occurred in 13 patients (26%); glucose metabolism was unchanged in 5 patients (10%). HbA1c was 7.8 ± 3.2% preoperatively and 6.2 ± 2.7% at 1 year (P < 0.001). Remission of diabetes was predicted by greater weight loss and a shorter history of diabetes (pseudo r2 = 0.44, P < 0.001). Improvement in diabetes was related to increased insulin sensitivity and ß-cell function. Weight loss was associated with significant improvements in fasting triglyceride level, HDL cholesterol level, hypertension, sleep, depression, appearance evaluation, and health-related quality of life. Early complications occurred in 6% of patients (wound infections in 4%, respiratory support in 2%), and late complications occurred in 30% of patients (gastric prolapse in 20%, band erosion in 6%, and tubing leaks in 4%). All late complications were successfully revised surgically.

CONCLUSIONS—Modern laparoscopic weight-loss surgery is effective in managing the broad range of health problems experienced by severely obese individuals with type 2 diabetes. Surgery should be considered as an early intervention.

Abbreviations: %EWL, percentage of excess weight loss • %EWL1, %EWL at 1 year • HOMA, homeostasis model assessment • HUMA%B, percentage of ß-islet cell function assessed by HOMA • HOMA%S, percentage of insulin sensitivy assessed by HOMA • LAGB, laparoscopically placed adjustable gastric band • pr2, pseudo r2


Add to CiteULike CiteULike   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
Eur J EndocrinolHome page
M. J F Bult, T. van Dalen, and A. F Muller
Surgical treatment of obesity
Eur. J. Endocrinol., February 1, 2008; 158(2): 135 - 145.
[Abstract] [Full Text] [PDF]


Home page
JAMAHome page
J. B. Dixon, P. E. O'Brien, J. Playfair, L. Chapman, L. M. Schachter, S. Skinner, J. Proietto, M. Bailey, and M. Anderson
Adjustable Gastric Banding and Conventional Therapy for Type 2 Diabetes: A Randomized Controlled Trial
JAMA, January 23, 2008; 299(3): 316 - 323.
[Abstract] [Full Text] [PDF]


Home page
Psychosom. Med.Home page
J. E. Elwing, P. J. Lustman, H. L. Wang, and R. E. Clouse
Depression, Anxiety, and Nonalcoholic Steatohepatitis
Psychosom Med, July 1, 2006; 68(4): 563 - 569.
[Abstract] [Full Text] [PDF]


Home page
Eur. J. Cardiothorac. Surg.Home page
C. H. Wigfield, J. D. Lindsey, A. Munoz, P. S. Chopra, N. M. Edwards, and R. B. Love
Is extreme obesity a risk factor for cardiac surgery? An analysis of patients with a BMI>/=40.
Eur. J. Cardiothorac. Surg., April 1, 2006; 29(4): 434 - 440.
[Abstract] [Full Text] [PDF]


Home page
Obstet GynecolHome page
J. B. Dixon, M. E. Dixon, and P. E. O'Brien
Birth Outcomes in Obese Women After Laparoscopic Adjustable Gastric Banding
Obstet. Gynecol., November 1, 2005; 106(5): 965 - 972.
[Abstract] [Full Text] [PDF]


Home page
Diabetes CareHome page
A. E. Pontiroli, F. Folli, M. Paganelli, G. Micheletto, P. Pizzocri, P. Vedani, F. Luisi, L. Perego, A. Morabito, and S. Bressani Doldi
Laparoscopic Gastric Banding Prevents Type 2 Diabetes and Arterial Hypertension and Induces Their Remission in Morbid Obesity: A 4-year case-controlled study
Diabetes Care, November 1, 2005; 28(11): 2703 - 2709.
[Abstract] [Full Text] [PDF]


Home page
Diabetes CareHome page
N. Scopinaro, G. M. Marinari, G. B. Camerini, F. S. Papadia, and G. F. Adami
Specific Effects of Biliopancreatic Diversion on the Major Components of Metabolic Syndrome: A long-term follow-up study
Diabetes Care, October 1, 2005; 28(10): 2406 - 2411.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
S. Camastra, M. Manco, A. Mari, S. Baldi, A. Gastaldelli, A. V. Greco, G. Mingrone, and E. Ferrannini
{beta}-Cell Function in Morbidly Obese Subjects During Free Living: Long-Term Effects of Weight Loss
Diabetes, August 1, 2005; 54(8): 2382 - 2389.
[Abstract] [Full Text] [PDF]


Home page
JPEN J Parenter Enteral NutrHome page
S. A. Shikora
Severe Obesity: A Growing Health Concern A.S.P.E.N. Should Not Ignore
JPEN J Parenter Enteral Nutr, July 1, 2005; 29(4): 288 - 297.
[Abstract] [Full Text] [PDF]


Home page
Clin. DiabetesHome page
The American Diabetes Association, the North American Association for the Study of Ob, and and the American Society for Clinical Nutrition
Weight Management Using Lifestyle Modification in the Prevention and Management of Type 2 Diabetes: Rationale and Strategies
Clin. Diabetes, July 1, 2005; 23(3): 130 - 136.
[Full Text] [PDF]


Home page
Diabetes CareHome page
J. B. Dixon, W. J. Pories, P. E. O'Brien, P. R. Schauer, and P. Zimmet
Surgery as an Effective Early Intervention for Diabesity: Why the reluctance?
Diabetes Care, February 1, 2005; 28(2): 472 - 474.
[Full Text] [PDF]


Home page
Diabetes CareHome page
B. E. Schneider and E. C. Mun
Surgical Management of Morbid Obesity
Diabetes Care, February 1, 2005; 28(2): 475 - 480.
[Full Text] [PDF]


Home page
Am. J. Clin. Nutr.Home page
S. Klein, N. F Sheard, X. Pi-Sunyer, A. Daly, J. Wylie-Rosett, K. Kulkarni, and N. G Clark
Weight management through lifestyle modification for the prevention and management of type 2 diabetes: rationale and strategies. A statement of the American Diabetes Association, the North American Association for the Study of Obesity, and the American Society for Clinical Nutrition
Am. J. Clinical Nutrition, August 1, 2004; 80(2): 257 - 263.
[Abstract] [Full Text] [PDF]


Home page
Diabetes CareHome page
S. Klein, N. F. Sheard, X. Pi-Sunyer, A. Daly, J. Wylie-Rosett, K. Kulkarni, and N. G. Clark
Weight Management Through Lifestyle Modification for the Prevention and Management of Type 2 Diabetes: Rationale and Strategies: A statement of the American Diabetes Association, the North American Association for the Study of Obesity, and the American Society for Clinical Nutrition
Diabetes Care, August 1, 2004; 27(8): 2067 - 2073.
[Full Text] [PDF]


Home page
British Journal of Diabetes & Vascular DiseaseHome page
J. Wilding
Obesity treatment: the key to managing the type 2 diabetes timebomb?
The British Journal of Diabetes & Vascular Disease, July 1, 2004; 4(4): 217 - 219.
[PDF]


Home page
British Journal of Diabetes & Vascular DiseaseHome page
J. Pinkney and D. Kerrigan
Review: When should bariatric surgery be used in the treatment of type 2 diabetes?
The British Journal of Diabetes & Vascular Disease, July 1, 2004; 4(4): 232 - 237.
[Abstract] [PDF]


Home page
Am. J. Clin. Nutr.Home page
D. E Kelley
Sugars and starch in the nutritional management of diabetes mellitus
Am. J. Clinical Nutrition, October 1, 2003; 78(4): 858S - 864.
[Abstract] [Full Text] [PDF]


Home page
Arch SurgHome page
P. E. O'Brien and J. B. Dixon
Laparoscopic Adjustable Gastric Banding in the Treatment of Morbid Obesity
Arch Surg, April 1, 2003; 138(4): 376 - 382.
[Full Text] [PDF]


Home page
Diabetes CareHome page
J. A. Tayek
Is Weight Loss a Cure for Type 2 Diabetes?
Diabetes Care, February 1, 2002; 25(2): 397 - 398.
[Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Diabetes Diabetes Care Clinical Diabetes Diabetes Spectrum
Copyright © 2002 by the American Diabetes Association.